Organization: National Research Council

NRC and Chinese S&T ministry sign innovation LOI

The National Research Council has signed a Letter of Intent with the Chinese Ministry of Science and Technology to promote, select and fund innovation-driven collaboration between small- and medium-sized enterprises from both nations. The LOI was signed last month in Ottawa as part of the 6th meeting of the Canada-China Joint Committee on Science, Technology…

CAE Healthcare launched NRC-developed neurosimulator

CAE Healthcare has launched a neurosurgery simulator for training surgeons developed by the National Research Council (NRC). The NeuroVR simulator is currently in use at 15 sites and has been validated in several clinical studies. The simulator has 37 training modules that provide a training environment for open cranial and endoscopic brain surgery procedures.The system…

Not-for-profits acquire three scholarly journals

Canadian Science Publishing (CSP) and the Agricultural Institute of Canada have joined forces to acquire three leading academic journals. Both organizations are not-for-profits with CSP being spun out of the National Research Council where it was known as NRC Research Press. The acquisition takes effect immediately and includes Canadian Journal of Animal Science, Canadian Journal…

NRC announces $25-million advanced materials centre

The National Research Council (NRC) will invest $25-million in a new Advanced Materials Manufacturing Centre (AMMC) to be co-located at the campus of Xerox Research Centre of Canada (XRCC) in Mississauga ON. The announcement was among a flurry of press releases released prior to the August 2nd call for a federal election. The AMMC augments…

NRC to spend $60 million on facility upgrades

The National Research Council (NRC) will spend $60 million on upgrading facilities across the country. Funding for the eight projects comes from a $380-million commitment made last fall for major repairs and upgrading of federal laboratories and research facilities (R$, November 27/14). They include general upgrades ($22 million), sewer work at NRC’s main Ottawa campus…

NRC to spend $60 million on facility upgrades

The National Research Council (NRC) will spend $60 million on upgrading facilities across the country. Funding for the eight projects comes from a $380-million commitment made last fall for major repairs and upgrading of federal laboratories and research facilities (R$, November 27/14). They include general upgrades ($22 million), sewer work at NRC’s main Ottawa campus…

Kalgene licenses NRC molecule for Alzheimer’s drug

Kingston-based Kalgene Pharmaceuticals Inc has been granted an exclusive worldwide licence from the National Research Council (NRC) for a promising therapeutic molecule in the fight against Alzheimer’s disease. The company aims to conduct pre-clinical testing of the molecule which targets amyloid beta plaques (abnormal clusters of protein fragments that build up between brain nerve cells)…

Kalgene licenses NRC molecule for Alzheimer’s drug

Kingston-based Kalgene Pharmaceuticals Inc has been granted an exclusive worldwide licence from the National Research Council (NRC) for a promising therapeutic molecule in the fight against Alzheimer’s disease. The company aims to conduct pre-clinical testing of the molecule which targets amyloid beta plaques (abnormal clusters of protein fragments that build up between brain nerve cells)…

NRC delegation visits Taiwan to explore collaboration

A delegation from the National Research Council recently visited Taiwan’s National Cheng Kung Univ (NCKU) to discuss collaboration on medical devices. Led by NRC life sciences VP Dr Roman Szumski, the delegation met with NCKU faculty to explore future collaboration, beginning with medical devices and possibly other areas of biomedical engineering. The NRC and Taiwan’s…

AvidBiologics completes VC financing round

Toronto-based AvidBiologics Inc has closed a financing round to move its antibody-drug conjugate (ADC) technologies into clinical trials. The privately held firm — a 2011 spinout from YM BioSciences Inc — secured an unspecified amount of financing from Lumira Capital (lead), MaRS Investment Accelerator Fund, MaRS Innovation, Rosseau Asset Management and the company’s founding investors.…